
The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …
Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
A new code of conduct has been drawn up for medical journals to help uncover conflicts of interest which could …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

